Evidence map›Paper›PMID 42422199›Full record

ArticleFrontiers in neurology

High-specificity identification of large vessel occlusion stroke using D-dimer and NT-proBNP combined with clinical variables.

Leire Azurmendi, J Gonzalez-Fraile, A Barragán-Prieto, S Reymond, R M Delgado, C de Jesús-Gil, A Penalba, J A Cabezas-Rodríguez, F Moniche, S Pérez-Sánchez and 3 more

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Leire AzurmendiDepartment of Internal Medicine, Faculty of Medicine, Geneva University, Genève, Switzerland.
J Gonzalez-FraileABCDx SL, Barcelona, Spain.
A Barragán-PrietoNeurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain.
S ReymondDepartment of Internal Medicine, Faculty of Medicine, Geneva University, Genève, Switzerland.
R M DelgadoNeurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain.
C de Jesús-GilABCDx SL, Barcelona, Spain.
A PenalbaNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
J A Cabezas-RodríguezNeurology Clinical Management Unit, Institute of Biomedicine of Seville, IBiS/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
F MonicheNeurology Clinical Management Unit, Institute of Biomedicine of Seville, IBiS/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
S Pérez-SánchezNeurology Clinical Management Unit, Institute of Biomedicine of Seville, IBiS/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
A González-GarciaNeurology Clinical Management Unit, Institute of Biomedicine of Seville, IBiS/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
J MontanerNeurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain.
J C SanchezDepartment of Internal Medicine, Faculty of Medicine, Geneva University, Genève, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rapid identification of large vessel occlusion (LVO) is essential to optimize prehospital triage and timely access to mechanical thrombectomy, yet current clinical scales show limited diagnostic performance, particularly when high specificity is required to ensure patient safety. Methods: We performed a prospective analysis of 290 consecutive patients with suspected acute ischemic stroke presenting within 24 h of symptom onset ( Results: A multimodal panel combining NT-proBNP, D-dimer, mean blood pressure, and the National Institutes of Health Stroke Scale (NIHSS) score demonstrated superior discrimination compared with individual biomarkers, clinical variables alone or any other considered biomarker-clinical combination. At a specificity of 90%, the panel achieved a sensitivity of 59.8% in the 24 h cohort. Among patients presenting within 6 h of symptom onset, sensitivity reached 65.7% while maintaining a specificity of 90.3%. Cross-validated Youden index estimates decreased to 0.44 in both cohorts, confirming modest optimism bias consistent with the exploratory design of this single-cohort study. Conclusion: The integration of circulating biomarkers with clinical variables improved the high-specificity identification of LVO. This multimodal approach should be interpreted as a rule-in enrichment strategy to support early triage and optimized routing of patients with a high probability of LVO, rather than as a rule-out tool to exclude LVO in lower-risk patients.

Indexed as

acute ischemic strokeblood biomarkersclinical scalesD-dimerlarge vessel occlusionmultivariable panelsNT-ProBNPprehospital triage

Identifiers

PMID42422199
PMCPMC13341300

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.